Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
21 December 2024 - 2:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of December 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
Block listing Application
Application has been made to the Financial Conduct Authority and
the London Stock Exchange plc for a total of 700,000 Ordinary
Shares of 31¼p each ('Shares') to be admitted to the Official
List.
The Shares are being reserved under a block listing and will be
issued under the GlaxoSmithKline plc Share Save Plan
2012.
When issued, the Shares will rank pari passu with the existing
Ordinary Shares of 31¼p each.
Admission is expected to be effective on 23 December
2024.
V A Whyte
Company Secretary
20 December 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: December
20, 2024
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Dec 2024 to Jan 2025
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jan 2024 to Jan 2025
